<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mimmun</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинская иммунология</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Immunology (Russia)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1563-0625</issn><issn pub-type="epub">2313-741X</issn><publisher><publisher-name>SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15789/1563-0625-2018-1-99-106</article-id><article-id custom-type="elpub" pub-id-type="custom">mimmun-1436</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>ТРИПТАЗА РОТОВОЙ ЖИДКОСТИ И IgE-АНТИТЕЛА КАК МАРКЕР АЛЛЕРГИЧЕСКОГО ВОСПАЛЕНИЯ СЛИЗИСТОЙ ОБОЛОЧКИ ПОЛОСТИ РТА</article-title><trans-title-group xml:lang="en"><trans-title>TRYPTASE OF ORAL LIQUID AND IgE-ANTIBODIES AS A MARKER OF ALLERGIC INFLAMMATION IN THE ORAL MUCOSA</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Карпук</surname><given-names>И. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Karpuk</surname><given-names>I. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., докторант кафедры клинической иммунологии и аллергологии с курсом ФПК и ПК</p></bio><bio xml:lang="en"><p>PhD (Medicine), Associate Professor, Department of Clinical Immunology and Allergology</p></bio><email xlink:type="simple">ikarpuk@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>УО «Витебский государственный медицинский университет», г. Витебск</institution><country>Беларусь</country></aff><aff xml:lang="en"><institution>Vitebsk State Medical University</institution><country>Belarus</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>11</day><month>01</month><year>2018</year></pub-date><volume>20</volume><issue>1</issue><fpage>99</fpage><lpage>106</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Карпук И.Ю., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Карпук И.Ю.</copyright-holder><copyright-holder xml:lang="en">Karpuk I.Y.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.mimmun.ru/mimmun/article/view/1436">https://www.mimmun.ru/mimmun/article/view/1436</self-uri><abstract><p>Целью исследования явилось определение концентрации триптазы тучных клеток (ТТК) в ротовой жидкости (РЖ) и IgE-антител в крови у пациентов с симптомами непереносимости стоматологических материалов (НСМ) до и после удаления причинных ортопедических конструкций. Проведено обследование пациентов, обратившихся с жалобами на НСМ, которые были разделены на 2 группы в зависимости от временного интервала между окончанием зубопротезирования и появлением патологических симптомов: 1 группа (n = 19) – от 1 до 14 суток (возникновение симптомов отмечалось сразу после протезирования, а в последующем они нарастали); 2 группа (n = 18) – от полугода до 5 лет; 3 группа (n = 16) – контрольная – без жалоб на НСМ. Образцы ротовой жидкости (РЖ) для измерения ТТК собирались у пациентов до снятия причинных ортопедических конструкций и через месяц после снятия. В группе пациентов с НСМ и возникновением симптомов НСМ на 1-е – 14-е сутки после протезирования ТТК в РЖ выявлялась у 16 (84,2%) пациентов до снятия причинных ортопедических конструкций, а через месяц после снятия ортопедических конструкций ТТК в РЖ не определялась (р ≤ 0,001). У пациентов контрольной группы ТТК в РЖ не определялась до и после снятия ортопедических конструкций. Таким образом, ТТК в РЖ является диагностическим маркером алергии на КСМ. У пациентов с возникновением симптомов НСМ на 1-е – 14-е сутки после протезирования выявлены IgE-антитела к: Ni-HSA – у 78,9% пациентов, Cr-HSA – у 68,4% пациентов, Co-HSA – у 52,6% пациентов. Уровень ТТК в РЖ сильно коррелировал с уровнем IgE-антител к NiHSA (RSpearman = 0,9; р &lt; 0,05) и Cr-HSA – умеренно (RSpearman = 0,7; р &lt; 0,05). Полученные данные указывают на превалирование немедленного типа реакции на КСМ. Выраженное локальное повышение уровня ТТК представляет собой важный патогенетический маркер местной инициации воспалительного процесса в полости рта. ТТК в РЖ выявлена только у 3 (16,7%) пациентов с возникновением симптомов НСМ от полугода до 5 лет (n = 18), и у них же IgE-антитела к металлам в сыворотке крови, что указывает на IgE-зависимый характер реакции у них. У остальных пациентов 2 группы, по-видимому, имеется иной тип аллергической реакции – замедленный, или гранулоцитопосредо- ванный. Для достоверной диагностики аллергии на компоненты стоматологических материалов целесообразно измерение ТТК в РЖ до и после снятия ортопедических конструкций. Мониторинг уровня ТТК в РЖ позволяет оценить причинность ортопедических конструкций в возникновении НСМ и необходимость замены их замены. </p></abstract><trans-abstract xml:lang="en"><p>The goal of present study was to determine the levels of mast cell tryptase (MCT) in whole saliva, and blood serum IgE antibodies in patients with intolerance for dental prosthetic materials (IDM) before and after removal of prosthetic constructs. We have conducted examination of the patients suffering from the IDM symptoms, who were divided into 2 groups depending on the time span between the end of prosthetic treatment and emergence of pathological symptoms: group 1 (n = 19), 1 to 14 days (symptoms emerged immediately after treatment); group 2, (n = 18), IDM symptoms occuring 6 months to 5 years later; group 3 (n = 16), controls without complaints for IDM. Whole saliva (WS) samples were collected before removal of prosthetic constructs and 1 month later. In group 1, salivary MCT was detected in 16 subjects (84.2%) before removal of prosthetic constructs, while 1 month after MCT not detectable in saliva (p &lt; 0.001). Salivary MCT in control group was not detected both before and after removal of prosthetic constructions. Hence, mast cell tryptase in whole saliva could be a diagnostic marker for intolerance to dental materials. In group 1 of the patients, we detected IgE antibodies to Ni-HSA in 78.9% of patients, IgE antibodies to Cr-HSA in 68.4% of patients and IgE to Co-HSA in 52.6% of patients. Salivary MCT levels strongly correlated with IgE levels to Ni-HSA (Rspearman = 0.9; p &lt; 0.05), showing moderate correlation with Cr-HSA (Rspearman = 0.7; p &lt; 0.05). The data obtained suggest some prevalence of immediate type immune reaction against dental materials. Notable local increase of MCT level could be an important diagnostic marker of local inflammatory process initiation. MCT in whole saliva was found only in 3 patients (16.7%) from group 2; those had IgE antibodies to metal ions in blood serum, thus indicating IgE-dependent reaction type. Other patients from group 2 were likely to develop a different type of allergic reaction, e. g. delayed or granulocyte-mediated response. To perform reliable diagnostics of allergy to the components of dental materials, it is reasonable to measure salivary MCT before and after removal of prosthetic constructs. Salivary MCT level monitoring allows to confirm a role of prosthetic constructs in IDM emergence, and a need for their replacement.</p><p> </p></trans-abstract><kwd-group xml:lang="ru"><kwd>аллергия</kwd><kwd>IgE-антитела</kwd><kwd>триптаза</kwd><kwd>тучные клетки</kwd><kwd>ротовая жидкость</kwd><kwd>стоматологические материалы</kwd></kwd-group><kwd-group xml:lang="en"><kwd>allergy</kwd><kwd>IgE-antibodies</kwd><kwd>tryptase</kwd><kwd>mast cells</kwd><kwd>whole saliva</kwd><kwd>dental materials</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Карпук Н.А., Карпук И.Ю. Диагностика аллергии на металлические изделия в реакции аллергениндуцированного повреждения лейкоцитов // Медицинские новости, 2012. № 6. С. 75-76. [Karpuk N.A., Karpuk I.Yu. Diagnosis of allergy to metal products in the reaction of allergenic-induced leukocyte damage. Meditsinskie novosti = Medical News, 2012, no. 6, pp. 75-76. (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Карпук Н.А., Карпук И.Ю. Диагностика аллергии на металлические изделия в реакции аллергениндуцированного повреждения лейкоцитов // Медицинские новости, 2012. № 6. С. 75-76. [Karpuk N.A., Karpuk I.Yu. Diagnosis of allergy to metal products in the reaction of allergenic-induced leukocyte damage. Meditsinskie novosti = Medical News, 2012, no. 6, pp. 75-76. (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Новиков Д.К., Новиков П.Д. Клиническая иммунопатология: руководство. М.: Медицинская литература, 2009. 464 с. [Novikov D.K., Novikov P.D. Clinical immunopathology: a guide]. Moscow: Medical Literature, 2009. 464 p.</mixed-citation><mixed-citation xml:lang="en">Новиков Д.К., Новиков П.Д. Клиническая иммунопатология: руководство. М.: Медицинская литература, 2009. 464 с. [Novikov D.K., Novikov P.D. Clinical immunopathology: a guide]. Moscow: Medical Literature, 2009. 464 p.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Новиков Д.К., Сергеев Ю.В., Новиков П.Д. Лекарственная аллергия. М.: Национальная академия микологии, 2001. 313 с. [Novikov D.K., Sergeev Yu.V., Novikov P.D. Medicinal allergy]. Moscow: National Academy of Mycology, 2001. 313 p. (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Новиков Д.К., Сергеев Ю.В., Новиков П.Д. Лекарственная аллергия. М.: Национальная академия микологии, 2001. 313 с. [Novikov D.K., Sergeev Yu.V., Novikov P.D. Medicinal allergy]. Moscow: National Academy of Mycology, 2001. 313 p. (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Новиков П.Д., Новиков Д.К., Титова Н.Д. Диагностика аллергии и гиперчувствительности: ведущее значение клеточных методов // Иммунопатология, аллергология, инфектология, 2016. № 4. С. 25-39. [Novikov P.D., Novikov D.K., Titova N.D. Diagnosis of allergy and hypersensitivity: the leading importance of cellular methods. Immunopatologiya, allergologiya, infektologiya = Immunopathology, Allergology, Infectology, 2016, no. 4, pp. 25-39. (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Новиков П.Д., Новиков Д.К., Титова Н.Д. Диагностика аллергии и гиперчувствительности: ведущее значение клеточных методов // Иммунопатология, аллергология, инфектология, 2016. № 4. С. 25-39. [Novikov P.D., Novikov D.K., Titova N.D. Diagnosis of allergy and hypersensitivity: the leading importance of cellular methods. Immunopatologiya, allergologiya, infektologiya = Immunopathology, Allergology, Infectology, 2016, no. 4, pp. 25-39. (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Blank U. The mechanisms of exocytosis in mast cells. Adv. Exp. Med. Biol., 2011, Vol. 716, pp. 107-122.</mixed-citation><mixed-citation xml:lang="en">Blank U. The mechanisms of exocytosis in mast cells. Adv. Exp. Med. Biol., 2011, Vol. 716, pp. 107-122.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Chen S., Mu D., Cui M., Ren C., Zhang S., Guo L., Gao W. Dynamic changes and clinical signiﬁcance of serum tryptase levels in STEMI patients treated with primary PCI. Biomarkers, 2014, Vol. 19, no. 7, pp. 620-624.</mixed-citation><mixed-citation xml:lang="en">Chen S., Mu D., Cui M., Ren C., Zhang S., Guo L., Gao W. Dynamic changes and clinical signiﬁcance of serum tryptase levels in STEMI patients treated with primary PCI. Biomarkers, 2014, Vol. 19, no. 7, pp. 620-624.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Jogie-Brahim S., Min H.K., Fukuoka Y., Xia H.Z., Schwartz L.B. Expression of alpha-tryptase and beta-tryptase by human basophils. J. Allergy Clin. Immunol., 2004, Vol. 113, no. 6, pp. 1086-1092.</mixed-citation><mixed-citation xml:lang="en">Jogie-Brahim S., Min H.K., Fukuoka Y., Xia H.Z., Schwartz L.B. Expression of alpha-tryptase and beta-tryptase by human basophils. J. Allergy Clin. Immunol., 2004, Vol. 113, no. 6, pp. 1086-1092.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Kumar V., Sharma A. Mast cells: emerging sentinel innate immune cells with diverse role in immunity. Mol. Immunol., 2010, Vol. 48, no. 1-3, pp. 14-25.</mixed-citation><mixed-citation xml:lang="en">Kumar V., Sharma A. Mast cells: emerging sentinel innate immune cells with diverse role in immunity. Mol. Immunol., 2010, Vol. 48, no. 1-3, pp. 14-25.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Lorentz A., Baumann A., Vitte J., Blank U. The SNARE machinery in mast cell secretion. Front. Immunol., 2012, Vol. 3, p. 143.</mixed-citation><mixed-citation xml:lang="en">Lorentz A., Baumann A., Vitte J., Blank U. The SNARE machinery in mast cell secretion. Front. Immunol., 2012, Vol. 3, p. 143.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Lundequist A., Pejler G. Biological implications of preformed mast cell mediators. Cell. Mol. Life Sci., 2011, Vol. 68, no. 6, pp. 965-975.</mixed-citation><mixed-citation xml:lang="en">Lundequist A., Pejler G. Biological implications of preformed mast cell mediators. Cell. Mol. Life Sci., 2011, Vol. 68, no. 6, pp. 965-975.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Niedoszytko M., Chełmińska M., Chełmiński K., Knopińska-Posłuszny W., Gruchała-Niedoszytko M., Jassem E. Late-phase allergic reaction in nasal provocation with fungal allergens. Allergy Asthma Proc., 2008, Vol. 29, no. 1, pp. 35-39.</mixed-citation><mixed-citation xml:lang="en">Niedoszytko M., Chełmińska M., Chełmiński K., Knopińska-Posłuszny W., Gruchała-Niedoszytko M., Jassem E. Late-phase allergic reaction in nasal provocation with fungal allergens. Allergy Asthma Proc., 2008, Vol. 29, no. 1, pp. 35-39.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Ruëﬀ F., Friedl T., Arnold A., Kramer M., Przybilla B. Release of mast cell tryptase into saliva: a tool to diagnose food allergy by a mucosal challenge test? Int. Arch. Allergy Immunol., 2011, Vol. 155, no. 3, pp. 282-288.</mixed-citation><mixed-citation xml:lang="en">Ruëﬀ F., Friedl T., Arnold A., Kramer M., Przybilla B. Release of mast cell tryptase into saliva: a tool to diagnose food allergy by a mucosal challenge test? Int. Arch. Allergy Immunol., 2011, Vol. 155, no. 3, pp. 282-288.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Sargur R., Cowley D., Murng S., Wild G., Green K., Shrimpton A., Egner W. Raised tryptase without anaphylaxis or mastocytosis: heterophilic antibody interference in the serum tryptase assay. Clin. Exp. Immunol., 2011, Vol. 163, no. 339-345.</mixed-citation><mixed-citation xml:lang="en">Sargur R., Cowley D., Murng S., Wild G., Green K., Shrimpton A., Egner W. Raised tryptase without anaphylaxis or mastocytosis: heterophilic antibody interference in the serum tryptase assay. Clin. Exp. Immunol., 2011, Vol. 163, no. 339-345.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Schliemann S., Seyfarth F., Hipler U.C., Elsner P. Impact of age and heterophilic interference on basal serum tryptase, a risk indication for anaphylaxis, in 1092 dermatology patients. Acta Derm. Venereol., 2012, Vol. 92, no. 5, pp. 484-489.</mixed-citation><mixed-citation xml:lang="en">Schliemann S., Seyfarth F., Hipler U.C., Elsner P. Impact of age and heterophilic interference on basal serum tryptase, a risk indication for anaphylaxis, in 1092 dermatology patients. Acta Derm. Venereol., 2012, Vol. 92, no. 5, pp. 484-489.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">St. John A.L., Abraham S.N. Innate immunity and its regulation by mast cells. J. Immunol., 2013, Vol. 190, no. 9, pp. 4458-4463.</mixed-citation><mixed-citation xml:lang="en">St. John A.L., Abraham S.N. Innate immunity and its regulation by mast cells. J. Immunol., 2013, Vol. 190, no. 9, pp. 4458-4463.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Trivedi N.N., Caughey G.G. Mast cell peptidases. Chameleons oﬁnnate immunity and host defense. Am. J. Respir. Cell Mol. Biol., 2010, Vol. 42, no. 3, pp. 257-267.</mixed-citation><mixed-citation xml:lang="en">Trivedi N.N., Caughey G.G. Mast cell peptidases. Chameleons oﬁnnate immunity and host defense. Am. J. Respir. Cell Mol. Biol., 2010, Vol. 42, no. 3, pp. 257-267.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Valent P. Mast cell activation syndromes: deﬁnition and classiﬁcation. Allergy, 2013, Vol. 68, no. 4, pp. 417-424.</mixed-citation><mixed-citation xml:lang="en">Valent P. Mast cell activation syndromes: deﬁnition and classiﬁcation. Allergy, 2013, Vol. 68, no. 4, pp. 417-424.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Valent P., Akin C., Arock M., Brockow K., Butterﬁeld J.H., Carter M.C., Castells M., Escribano L., Hartmann K., Lieberman P., Nedoszytko B., Orfao A., Schwartz L.B., Sotlar K., Sperr W.R., Triggiani M., Valenta R., Horny H.P., Metcalfe D.D. Deﬁnitions, criteria and global classi- ﬁcations of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal. Int. Arch. Allergy Clin. Immunol., 2012, Vol. 157, no. 3, pp. 215-225.</mixed-citation><mixed-citation xml:lang="en">Valent P., Akin C., Arock M., Brockow K., Butterﬁeld J.H., Carter M.C., Castells M., Escribano L., Hartmann K., Lieberman P., Nedoszytko B., Orfao A., Schwartz L.B., Sotlar K., Sperr W.R., Triggiani M., Valenta R., Horny H.P., Metcalfe D.D. Deﬁnitions, criteria and global classi- ﬁcations of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal. Int. Arch. Allergy Clin. Immunol., 2012, Vol. 157, no. 3, pp. 215-225.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Vitte J. Human mast cell tryptase in biology and medicine. Mol. Immunol., 2015, Vol. 63, no. 1, pp. 18-24.</mixed-citation><mixed-citation xml:lang="en">Vitte J. Human mast cell tryptase in biology and medicine. Mol. Immunol., 2015, Vol. 63, no. 1, pp. 18-24.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Voehringer D. Protective and pathological roles of mast cells and basophils. Nat. Rev. Immunol., 2013, Vol. 13, pp. 362-375.</mixed-citation><mixed-citation xml:lang="en">Voehringer D. Protective and pathological roles of mast cells and basophils. Nat. Rev. Immunol., 2013, Vol. 13, pp. 362-375.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
